Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
57,779,618
-
Share change
-
+2,092,071
-
Total reported value
-
$3,648,879,764
-
Put/Call ratio
-
94%
-
Price per share
-
$63.17
-
Number of holders
-
193
-
Value change
-
+$129,623,911
-
Number of buys
-
100
-
Number of sells
-
98
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q2 2014
As of 30 Jun 2014 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 57,779,618 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT CO LLP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, GILDER GAGNON HOWE & CO LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and BAILLIE GIFFORD & CO.
This table shows 190 institutional shareholders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.